Passionate about making a profound impact on patients’ lives

Assembly Bio is an ambitious clinical stage biopharmaceutical company with cutting-edge therapeutic product candidates capable of improving the lives of millions living with chronic hepatitis B virus (HBV) infection around the world.

Focused on Transforming HBV Treatment

Assembly Bio’s team aspires to deliver finite and curative treatments for HBV, one of the world’s most prevalent and devastating infectious diseases.

Explore our HBV program.


Board of Directors

William Ringo

Chairman of the Board, Non-Executive

Anthony Altig

Director

Gina Consylman

Director

Richard DiMarchi, PhD

Director

Myron Z. Holubiak

Director

Sir Michael Houghton, PhD

Director

Lisa Johnson-Pratt, MD

Director

Sue Mahony, PhD

Director

John McHutchison AO, MD

Chief Executive Officer & President, Director

Scientific Advisory Board

Antonio Bertoletti, MD

Richard DiMarchi, PhD

Edward J. Gane, MBCHB, MD, FRACP, MNZM

Patrick Kennedy, MB BCh BAO BMedSci FR CP MD

Prof Stephen Locarnini, BSc (Hons), PhD, MBBS, FRC (Path)

Alex Thompson, MBBS, PhD, FRACP

Stephan Urban, PhD

Adam Zlotnick, PhD

Fabien Zoulim, MD, PhD

Contact Us

CORPORATE HEADQUARTERS
331 Oyster Point Blvd.
4th Floor
South San Francisco, CA 94080

Get Directions

FOR GENERAL INFORMATION,
PLEASE CONTACT:

833.509.4583
info@assemblybio.com

FOR QUESTIONS ABOUT COLLABORATION
OPPORTUNITIES, PLEASE CONTACT:

BD@assemblybio.com